HOW ARE PATIENT EXPERIENCE DATA REPORTED IN REGULATORY EVALUATION OF MEDICINAL PRODUCTS? A DOCUMENT ANALYSIS OF EUROPEAN PUBLIC ASSESSMENT REPORTS

被引：0
|
作者：
Verbeke, C. [1 ]
Cuppens, J. [1 ]
Huys, I [1 ]
Barbier, L. [1 ]
Janssens, R. [1 ]
机构：
[1] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR138
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 17 条
  • [11] Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
    Maximilian Siebert
    Jeanne Gaba
    Alain Renault
    Bruno Laviolle
    Clara Locher
    David Moher
    Florian Naudet
    BMC Medicine, 20
  • [12] Data-sharing and re-analysis for main studies assessed by the European Medicines Agency-a cross-sectional study on European Public Assessment Reports
    Siebert, Maximilian
    Gaba, Jeanne
    Renault, Alain
    Laviolle, Bruno
    Locher, Clara
    Moher, David
    Naudet, Florian
    BMC MEDICINE, 2022, 20 (01)
  • [13] Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
    Olivier Chassany
    Pierre Sagnier
    Patrick Marquis
    Steve Fullerton
    Neil Aaronson
    Drug information journal : DIJ / Drug Information Association, 2002, 36 (1): : 209 - 238
  • [14] Patient-reported outcomes: The example of health-related quality of life - A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process
    Chassany, O
    Sagnier, P
    Marquis, P
    Fullerton, S
    Aaronson, N
    DRUG INFORMATION JOURNAL, 2002, 36 (01): : 209 - 238
  • [15] Evaluation of EU Post-Authorization Safety Studies Using EU-RMP/European Public Assessment Reports: Analysis, Trends, and Implications
    Neasham, David
    Baradaran, Sarah
    Chalkiadaki, Corina
    Sadasivan, Ravi
    Nordstrom, Beth L.
    Reynolds, Matthew W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 440 - 441
  • [16] Health-Related Quality of Life (HR-QOL) and Regulatory IssuesAn Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval
    Giovanni Apolone
    Gianfranco De Carli
    Massimo Brunetti
    Silvio Garattini
    PharmacoEconomics, 2001, 19 : 187 - 195
  • [17] Health-related quality of life (HR-QOL) and regulatory issues - An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval
    Apolone, G
    De Carli, G
    Brunetti, M
    Garattini, S
    PHARMACOECONOMICS, 2001, 19 (02) : 187 - 195
12